Figure 9: Chemical structures of EGFR inhibitors used for radiolabeling. Labeled EGFR reversible inhibitors (PD153035 analogs and [18F]ML01) [21, 22] and labeled EGFR irreversible inhibitors (ML04 analogs, [11C]ML03, and [18F]ML10) [23–25].